Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study

Human Genetics

Volumn 133, Issue 9, 2014, Pages 1105-1116

  Lusk, Christine M ^a   Dyson, Greg ^b   Clark, Andrew G ^c   Ballantyne, Christie M ^d,e   Frikke Schmidt, Ruth ^f,g   Tybjærg Hansen, Anne ^f,g   Boerwinkle, Eric ^d,h   Sing, Charles F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Cornell University ^*  (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^f University of Copenhagen   (Denmark)

^g Mental Health Center Glostrup   (Denmark)

^h UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 9P; CHROMOSOME 9P21; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROSCLEROSIS; CHROMOSOMES, HUMAN, PAIR 9; COHORT STUDIES; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MARYLAND; MIDDLE AGED; MINNESOTA; MISSISSIPPI; NORTH CAROLINA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84907424056     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-014-1451-3     Document Type: Article

References (70)

1. Almontashiri NA, Fan M, Cheng BL, Chen HH, Roberts R, Stewart AF (2013) Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype. J Am Coll Cardiol 61:143–147
2. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27:S5–S10
3. Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, Tang H, Absher DLJ, Fair JM, Rubin GD et al (2008) Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet 17:2320–2328
4. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
5. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, Willerson JT, Boerwinkle E (2009) Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Genet 2:279–285
6. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, Goldstein BA et al (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45:25–33
7. Chobanian AV (1992) Pathophysiology of hypertension. Am J Cardiol 70:3G–7G
8. Cowper-Sal Iari R, Cole MD, Karagas MR, Lupien M, Moore JH (2011) Layers of epistasis: genome-wide regulatory networks and network approaches to genome-wide association studies. Wiley Interdiscip Rev Syst Biol Med 3:513–526
9. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B (2010) Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet 6:e1000899
10. Do R, Xie C, Zhang X, Männistö S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R (2012) The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. PLoS Med 8:e1001106
11. Dominguez-Brauer C, Brauer PM, Chen Y-J, Pimkina J, Raychaudhuri P (2010) Tumor suppression by ARF: gatekeeper and caretaker. Cell Cycle 9:86–89
12. Dong L, Wang H, Wang DW, Ding H (2013) Association of chromosome 9p21 genetic variants with risk of coronary heart disease in the East Asian population: a meta-analysis. Ann Hum Genet 77:183–190
13. Dyson G, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A, Sing CF (2007) An application of the patient rule-induction method for evaluating the contribution of the apolipoprotein E and lipoprotein lipase genes to predicting ischemic heart disease. Genet Epidemiol 31:515–527
14. Dyson G, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A, Sing CF (2009) Modifications to the patient rule-induction method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease. Genet Epidemiol 33:317–324
15. Expert Panel of the National Cholesterol Education Program (2002) Detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Institutes of Health
16. Folsom AR, Nambi V, Pankow JS, Tang W, Farbakhsh K, Yamagishi K, Boerwinkle E (2012) Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 224:435–439
17. Frankel WN, Schork NJ (1996) Who’s afraid of epistasis? Nat Genet 14:371–373
18. Freis ED (1969) Hypertension and atherosclerosis. Am J Med 46:735–740
19. Friedman JH, Fisher NI (1999) Bump-hunting for high dimensional data. Stat Comp 9:123–143
20. Frikke-Schmidt R, Sing CF, Nordestgaard BG, Tybjaerg-Hansen A (2004) Gender- and age-specific contributions of additional DNA sequence variation in the 5′ regulatory region of the APOE gene to prediction of measures of lipid metabolism. Hum Genet 115:331–345
21. Frikke-Schmidt R, Nordestgaard BG, Stene MC, Sethi AA, Remaley AT, Schnor P, Grande P, Tybjaerg-Hansen A (2008) Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 299:2524–2532
22. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707–714
23. Haase CL, Tybjaerg-Hansen A, Grande P, Frikke-Schmidt R (2010) Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease. J Clin Endocrinol Metab 95:E500–E510
24. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, Frazer KA (2011) 9p21 DNA variants associated with coronary artery disease impair interferon-γ signaling response. Nature 470:264–268
25. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A et al (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316:1491–1493
26. Holdt LM, Teupser D (2012) Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 32:196–206
27. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, Bergert H, Schuler G, Thiery J, Teupser D (2010) ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 30:620–627
28. Hollander W (1976) Role of hypertension in atherosclerosis and cardiovascular disease. Am J Cardiol 38:786–800
29. Hu WL, Li SJ, Lu DT, Wang Y, Niu SQ, Yang XC, Zhang Q, Yu SZ, Jin L, Wang XF (2009) Genetic variants on chromosome 9p21 and ischemic stroke in Chinese. Brain Res Bull 79:431–435
30. IBC 50K CAD Consortium (2011) Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 7:e1002260
31. Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262
32. Johnson AD, Hwang S-J, Voorman A, Morrison A, Peloso GM, Hsu Y-H, Thanassoulis G, Newton-Cheh C, Rogers IS, Hoffmann U et al (2013) Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham Heart Study. Circulation 127:799–810
33. Jones DW, Hall JE (2004) Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure and evidence from new hypertension trials. Hypertension 43:1–3
34. Kannel WB (1990) CHD risk factors: a Framingham study update. Hosp Pract 25:119–127
35. Lee JY, Lee BS, Shin DJ, Woo Park K, Shin YA, Joong Kim K, Heo L, Young Lee J, Kyoung Kim Y, Jin Kim Y et al (2013) A genome-wide study of a coronary artery disease risk variant. J Hum Genet 58:120–126
36. Lehner B (2011) Molecular mechanisms of epistasis within and between genes. Trends Genet 27:323–331
37. Lewontin R (2002) Triple helix: gene, organism, and environment. Harvard University Press, Cambridge
38. Lusis AJ (2000) Atherosclerosis. Nature 407:233–241
39. Machado DB, Crow RS, Bolan LL, Hannan PJ, Taylor HA, Folsom AR (2006) Electrocardiographic findings and incident coronary heart disease among participants in the Atherosclerosis Risk in Communities (ARIC) study. Am J Cardiol 97:1176–1181
40. Mackay TF (2001) The genetic architecture of quantitative traits. Annu Rev Genet 35:303–339
41. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR et al (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488–1491
42. Motterle A, Pu X, Wood H, Xiao Q, Gor S, Ng FL, Chan K, Cross F, Shohreh B, Poston RN et al (2012) Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Hum Mol Genet 21:4021–4029
43. Musunuru K (2013) Enduring mystery of the 9p21.3 locus. Circ Cardiovasc Genet 6:224–225
44. Nägele U, Hägele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W (1984) Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Biochem 22:165–174
45. Nambi V, Boerwinkle E, Lawson K, Chambless L, Brautbar A, Franeschini N, North KE, Virani SS (2012) The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 222:135–137
46. Neel JV, Schull WJ (1954) Human heredity. University of Chicago Press, Chicago
47. Noble D (2006) The music of life: biology beyond the genome. Oxford University Press, New York
48. Noble D (2008) Genes and causation. Phil Trans R Soc A 366:3001–3015
49. Palomaki GE, Melillo S, Bradley LA (2010) Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA 303:648–656
50. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM (2009) Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3: The Women’s Genome Health Study. Ann Intern Med 150:65–72
51. Rimoin DL, Connor JM, Pyeritz RE, Korf BR (2006) Principles and practice of medical genetics. Churchill Livingstone/Elsevier, London
52. Roberts R, Stewart AFR (2012) 9p21 And the genetic revolution for coronary artery disease. Clin Chem 58:104–112
53. Schiffrin EL (1998) Endothelin:role in hypertension. Biol Res 31:199–208
54. Schnohr P, Appleyard M, Nordestgaard BG, Jensen JS, Jensen GB, Lange P, Grønbaek M, Prescott E (2001) The Copenhagen City Heart Study. Eur Heart J Supp 3:1–83
55. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AFR, Barbalic M, Gieger C et al (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43:333–338
56. Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (2000) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York
57. Shiffman D, O’Meara ES, Rowland CM, Louie JZ, Cushman M, Tracy RP, Devlin JJ, Psaty BM (2011) The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study. BMC Cardiovasc Disord 11:10
58. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075–1080
59. Simon A, Megnien JL, Levenson J (1997) Detection of preclinical atherosclerosis may optimize the management of hypertension. Am J Hypertens 10:813–824
60. Sing CF, Stengård JH, Kardia SL (2003) Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23:1190–1196
61. Stengård JH, Frikke-Schmidt R, Tybjaerg-Hansen A, Nordestgaard BG, Sing CF (2007) Variation in 5′ promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study. Ann Hum Genet 71:762–771
62. Talmud PJ, Cooper JA, Palmen J, Lovering R, Drenos F, Hingorani AD, Humphries SE (2008) Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 54:467–474
63. Templeton AR (2006) Population genetics and microevolutionary theory. Wiley, Hoboken
64. The ARIC Investigators (1989) The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129:687–702
65. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678
66. Wang X, Elston RC, Zhu X (2010) The meaning of interaction. Hum Hered 70:269–277
67. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 28:1379–1388
68. Weiss KM, Buchanan AV (2009) The cooperative genome: organisms as social contracts. Int J Dev Biol 53:753–763
69. Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S (2008) Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 52:378–384
70. Zeller T, Blankenberg S, Diemart P (2012) Genome-wide association studies in cardiovascular disease-an update 2011. Clin Chem 58:92–103